Through a series of assays including FHC knockdown and forced overexpression, we demonstrate for the first time that ferritin heavy subunit, through its ability to modulate ROS amounts, is a key element in determining the response of ovarian cancer cells to cisplatin exposure. The gene discussed is FTH1; the disease is ovarian carcinoma.